7.1 Acute Kidney Injury (AKI): Pathophysiology, IRIS Staging & Renal Replacement Therapy
Key Takeaways
- Acute Kidney Injury (AKI) is classified pathophysiologically into Pre-renal (hemodynamic hypoperfusion), Intrinsic (nephrotoxins like lilies, ethylene glycol, aminoglycosides, NSAIDs, leptospirosis, or ischemic ATN), and Post-renal (obstruction or rupture).
- The International Renal Interest Society (IRIS) AKI grading system stratifies injury from Grade I (< 1.6 mg/dL with documented active kidney injury) to Grade V (> 10.0 mg/dL), with critical subgrades for oliguria/anuria and requirement for renal replacement therapy (RRT).
- Fluid challenge and resuscitation must achieve euvolemia without causing overhydration; serial body weight measurements (q6-12h), strict ins-and-outs monitoring, and central venous pressure (CVP) prevent fatal pulmonary and renal interstitial edema.
- Pharmacologic conversion of oliguric to non-oliguric AKI (using Fenoldopam DA-1 agonist CRI or Furosemide CRI) must only be attempted once intravascular volume and renal perfusion pressure are fully restored.
- Renal Replacement Therapy (IHD or CRRT) is life-saving and definitively indicated for refractory hyperkalemia, severe fluid overload/pulmonary edema, intractable metabolic acidosis, and dialyzable nephrotoxicities.
Acute Kidney Injury (AKI): Pathophysiology, IRIS Staging & Renal Replacement Therapy
VTS Core Principle: Acute Kidney Injury (AKI) represents an abrupt, severe decline in glomerular filtration rate (GFR) occurring over hours to days. This failure of renal filtration, excretory, and homeostatic function precipitates rapid accumulation of nitrogenous waste products (azotemia/uremia), severe metabolic acidosis, life-threatening hyperkalemia, and dysregulated fluid balance. Early identification of the underlying etiology, aggressive hemodynamic optimization, and strict monitoring of urine production are critical to preventing irreversible renal parenchymal necrosis.
1. Pathophysiological Mechanisms & Etiological Classification of AKI
AKI is clinically and pathophysiologically divided into three distinct categories based on the anatomical site and mechanism of the underlying insult: Pre-renal, Intrinsic (Renal Parenchymal), and Post-renal.
┌─────────────────────────────────────────────────────────────────────────────┐
│ ETIOLOGICAL CLASSIFICATION OF AKI │
├──────────────────────┬───────────────────────────────┬──────────────────────┤
│ 1. PRE-RENAL │ 2. INTRINSIC (RENAL) │ 3. POST-RENAL │
│ (Hemodynamic) │ (Parenchymal Damage) │ (Obstructive) │
├──────────────────────┼───────────────────────────────┼──────────────────────┤
│ • Hypovolemic shock │ • Nephrotoxins (Lilies, EG) │ • Urethral plug/stone│
│ • Severe dehydration │ • Ischemic ATN (Heatstroke) │ • Bilateral ureteral │
│ • Hypotension/Sepsis │ • Infectious (Leptospirosis) │ obstruction │
│ • Congestive heart │ • Nephrotoxic Drugs (Aminos, │ • Uroabdomen / │
│ failure (Cardio- │ NSAIDs, Amphotericin B) │ Urinary tract │
│ renal syndrome) │ • Interstitial nephritis │ rupture │
└──────────────────────┴───────────────────────────────┴──────────────────────┘
1. Pre-Renal AKI (Hemodynamic / Hypoperfusion)
Pre-renal azotemia occurs when inadequate systemic arterial blood volume or reduced renal perfusion pressure drops glomerular capillary hydrostatic pressure below the threshold required for ultrafiltration (MAP < 60-65 mmHg):
- Etiologies: Severe hypovolemic shock, massive hemorrhage, severe dehydration, distributive septic vasoplegia, and low-output cardiogenic shock (Cardiorenal Syndrome Type 1).
- Pathophysiology: Afferent arteriolar vasoconstriction occurs secondary to systemic sympathetic activation and angiotensin II release. If renal blood flow (RBF) is restored promptly via fluid resuscitation and inotropic support, GFR recovers immediately without structural tubular injury. However, if prolonged, pre-renal hypoperfusion progresses to severe ischemic Acute Tubular Necrosis (ATN).
2. Intrinsic (Renal Parenchymal) AKI
Intrinsic AKI involves structural, cellular damage to the renal glomeruli, tubules, interstitium, or vasculature.
| Intrinsic Insult Class | Specific Etiological Agents | Cellular Mechanism of Renal Injury | Distinctive Clinical Findings |
|---|---|---|---|
| Nephrotoxic Plants & Foods | Lilies (Lilium and Hemerocallis spp. in cats); Grapes / Raisins (dogs) | Severe acute necrosis of renal proximal tubular epithelial cells; casts obstruct tubular lumens | Cat eating flowers/pollen; acute vomiting, severe depression, marked isosthenuria, glucosuria with euglycemia |
| Toxic Industrial Chemicals | Ethylene Glycol (Antifreeze) | Hepatic oxidation produces glycolic acid (causes profound metabolic acidosis) and oxalic acid, which binds calcium to form calcium oxalate monohydrate crystals that occlude tubules | Severe high anion-gap metabolic acidosis, ionized hypocalcemia, early ataxia/drunkenness, pica/vomiting, "picket-fence" calcium oxalate monohydrate crystals in urine sediment |
| Nephrotoxic Antimicrobials | Aminoglycosides (Gentamicin, Amikacin); Amphotericin B | Direct proximal tubular cytotoxicity: accumulation in lysosomes triggers cellular swelling, mitochondrial rupture, necrosis, and cast formation | Granular casts on urinalysis precede azotemia; non-oliguric AKI; ototoxicity |
| NSAIDs | Carprofen, Meloxicam, Flunixin meglumine, Ibuprofen | Inhibition of renal Cyclooxygenase (COX-1/COX-2) abolishes protective vasodilatory prostaglandins (PGE2, PGI2), triggering catastrophic renal medullary ischemia and renal papillary necrosis | High risk during concurrent hypovolemia, dehydration, or hypotension; gastrointestinal ulceration |
| Infectious Disease | Leptospirosis (Leptospira interrogans serovars: Grippotyphosa, Pomona, Australis, etc.) | Bacterial colonization of renal tubular epithelial microvilli induces intense acute tubulointerstitial nephritis, endothelial damage, and microvascular thrombosis | Concurrent acute hepatic injury (icterus, elevated ALP/ALT/Total Bilirubin), thrombocytopenia, pulmonary hemorrhage syndrome, fever, vasculitis |
| Ischemic Acute Tubular Necrosis (ATN) | Heatstroke, prolonged surgical hypotension, DIC, systemic sepsis, thromboembolism | Severe ATP depletion, loss of tubular brush borders, shedding of necrotic epithelial cells forming occlusive intraluminal cellular/granular casts, and back-leak of filtrate into renal interstitium | Marked renal swelling, loss of corticomedullary distinction on ultrasound, refractory oliguria |
3. Post-Renal AKI (Obstructive & Disruptive)
Post-renal AKI results from mechanical impediment to urine flow or disruption of the collecting system:
- Etiologies: Feline urethral obstruction (FLUTD), canine urolithiasis, bilateral ureteral obstruction (ureteroliths or strictures), solitary kidney ureteral obstruction, bladder neck neoplasia (TCC), or urinary tract rupture (uroabdomen).
- Pathophysiology: Back-pressure in Bowman's space rapidly matches and opposes glomerular capillary hydrostatic pressure, halting effective net ultrafiltration.
2. IRIS AKI Staging & Classification System
The International Renal Interest Society (IRIS) has established a consensus grading system for Acute Kidney Injury in dogs and cats based on serum creatinine concentrations, clinical evidence of active renal damage, and physiological subgrading.
IRIS AKI Grading Scale
| IRIS AKI Grade | Serum Creatinine (mg/dL) | Serum Creatinine (µmol/L) | Pathophysiologic & Diagnostic Description |
|---|---|---|---|
| Grade I | < 1.6 (Dogs & Cats) | < 140 | Non-azotemic AKI: Documented acute renal injury despite normal baseline creatinine. Criteria include: acute rise in serum creatinine >= 0.3 mg/dL (26.4 mcmol/L) within 48 hours; documented oliguria/anuria for > 6 hours; known acute nephrotoxic exposure (lily, antifreeze); or progressive imaging/histopathologic lesions. |
| Grade II | 1.7 – 2.5 | 141 – 220 | Mild AKI: Mild azotemia with documented active renal parenchymal injury or failure to respond to fluid challenge. |
| Grade III | 2.6 – 5.0 | 221 – 439 | Moderate AKI: Marked functional loss; systemic uremic signs (vomiting, anorexia, lethargy) manifest. |
| Grade IV | 5.1 – 10.0 | 440 – 880 | Severe AKI: Severe parenchymal decompensation; pronounced hyperphosphatemia, metabolic acidosis, and electrolyte derangements. |
| Grade V | > 10.0 | > 880 | Extreme / Critical AKI: Severe life-threatening uremic crisis; high mortality without advanced extracorporeal renal replacement. |
IRIS Subgrading: Urine Output & Dialysis Dependence
Every IRIS AKI grade is assigned a subgrade based on urine production volume and the need for renal replacement therapy:
- Non-Oliguric (NO): Urine output >= 1.0 mL/kg/hr in dogs and cats (or baseline spontaneous voiding >= 0.5-1.0 mL/kg/hr). Non-oliguric AKI carries a significantly better clinical prognosis because fluid, electrolyte, and nutritional support can be delivered without rapidly inducing volume overload.
- Oliguric (O): Urine output < 1.0 mL/kg/hr in dogs (or < 2.0 mL/kg/hr while receiving maintenance/replacement IV fluid therapy) over a measured period of 6 hours, persisting after intravascular volume depletion has been fully corrected.
- Anuric (A): Urine output < 0.1 mL/kg/hr or complete absence of urine production over 6 to 12 hours despite adequate renal perfusion pressure.
- Renal Replacement Therapy (RRT): Appended to the grade (e.g., Grade IV (O, RRT)) indicating the patient requires intermittent hemodialysis (IHD) or continuous renal replacement therapy (CRRT) for survival.
3. Fluid Resuscitation vs. Overhydration Monitoring in the ICU
The cornerstone of early AKI therapy is restoring normovolemia to maximize renal perfusion. However, once intravascular volume is re-established, the injured kidney may be incapable of excreting excess water and sodium. Fluid overload is an independent predictor of mortality in veterinary AKI.
┌─────────────────────────────────────────────────────────────────────────────┐
│ THE ICEBERG OF FLUID OVERHYDRATION │
├─────────────────────────────────────────────────────────────────────────────┤
│ VISIBLE SIGNS: Chemosis (scleral edema), Serous nasal discharge, │
│ Submandibular edema, Ascites, Peripheral pitting edema │
│ HEMODYNAMIC: Increased CVP (> 8-10 cmH2O), Gallop rhythm, Hypertension │
│ PULMONARY: Tachypnea, Lung crackles, B-lines on POCUS, Pleural effusion│
│ RENAL IMPACT: Renal interstitial edema --> Capsule tension --> │
│ Intrarenal compartment syndrome --> DROPS GFR FURTHER │
└─────────────────────────────────────────────────────────────────────────────┘
Precision Overhydration Monitoring Protocol
- Serial Calibrated Body Weight (q6-12h): The single most sensitive and rapid metric for acute fluid retention. An acute gain of 1.0 kg body weight equals exactly 1.0 Liter (1,000 mL) of retained fluid. Patients must be weighed on the identical electronic scale with all catheters, collars, and bandages accounted for.
- Ins-and-Outs Quantification (q1-4h): Place a sterile, closed, indwelling Foley or red rubber urinary collection system. Calculate total intake (maintenance crystalloids, drug CRIs, fluid flushes, blood products, tube feedings) and subtract measured output (urine volume, vomitus, diarrhea, thoracic/abdominal drain volume). When Intake exceeds Output in an already normovolemic patient, IV fluid rates must be immediately reduced to match output plus insensible losses (15-20 mL/kg/day or ~0.7-1.0 mL/kg/hr).
- Central Venous Pressure (CVP): Measured via a central jugular catheter positioned at the junction of the cranial vena cava and right atrium. Normal CVP is 0-5 cmH2O. A sustained rise to > 8-10 cmH2O indicates elevated right atrial filling pressure and dangerous intravascular overexpansion.
- Point-of-Care Ultrasound (POCUS / VetBLUE): Serial evaluation of lung fields for vertical artifact B-lines ("wet lung" rockets) and development of pleural/peritoneal fluid accumulation.
4. Pharmacologic Interventions in Oliguric AKI
Pharmacologic diuresis should NEVER be administered to a hypovolemic, dehydrated patient. It must only be considered in an euvolemic, normotensive patient that remains oliguric (UOP < 1.0 mL/kg/hr) despite aggressive hemodynamic resuscitation.
| Pharmacologic Agent | Mechanism of Action | Clinical Dosage & Administration | Therapeutic Goals & Clinical Limitations |
|---|---|---|---|
| Fenoldopam | Selective Dopamine-1 (DA1) receptor agonist | 0.1 – 0.8 mcg/kg/min IV CRI | Induces selective renal vasodilation, increases renal cortical blood flow, enhances GFR, and stimulates natriuresis. Unlike non-specific dopamine, fenoldopam does not stimulate alpha-adrenergic vasoconstriction or beta-1 adrenergic tachyarrhythmias at high doses. Preferred agent for feline/canine oliguric AKI. |
| Furosemide | High-ceiling loop diuretic; inhibits Na+/K+/2Cl- cotransporter in thick ascending limb of Henle | 1.0 – 2.0 mg/kg IV bolus test dose, followed by 0.25 – 1.0 mg/kg/hr IV CRI | Converts oliguric AKI to non-oliguric AKI to facilitate fluid/nutrient delivery and hyperkalemia management. Furosemide does NOT improve GFR or accelerate intrinsic nephron healing. If no diuretic response occurs within 2-4 hours, stop infusion to avoid ototoxicity. |
| Diltiazem | Non-dihydropyridine L-type Calcium Channel Blocker | 0.1 – 0.5 mg/kg slow IV bolus, then 1 – 5 mcg/kg/min CRI | Inhibits intracellular calcium influx in ischemic tubular cells, reducing cellular swelling and mitochondrial destruction; promotes renal arteriolar vasodilation. Used primarily in canine leptospirosis and ischemic insults. Monitor for bradycardia and hypotension. |
| Mannitol | Hypertonic osmotic diuretic (20-25%) | 0.25 – 0.5 g/kg slow IV over 15-20 min (via in-line filter) | Increases tubular fluid osmolality, promotes osmotic diuresis, and reduces cellular edema. Strictly contraindicated in overhydrated, anuric, or congestive heart failure patients due to acute expansion of intravascular volume predisposing to fatal pulmonary edema. |
5. Indications for Extracorporeal Renal Replacement Therapy (RRT)
When conservative medical therapy fails to arrest the metabolic deterioration of AKI, Renal Replacement Therapy—encompassing Intermittent Hemodialysis (IHD) and Continuous Renal Replacement Therapy (CRRT: CVVH, CVVHD, CVVHDF)—is the definitive life-saving modality.
Absolute Clinical Indications for RRT Initiation
- Refractory Hyperkalemia (K+ > 6.5-7.0 mEq/L): Cardiac conduction abnormalities persisting despite medical therapies (calcium gluconate, insulin/dextrose, terbutaline).
- Refractory Volume Overload / Pulmonary Edema: Progressive fluid retention and hypoxemia in an oliguric/anuric patient failing to respond to loop diuretics.
- Intractable Severe Metabolic Acidosis (pH < 7.15, HCO3- < 10 mEq/L): Unresponsive to balanced fluid therapy.
- Severe Uremic Complications: Blood Urea Nitrogen (BUN > 150-200 mg/dL), serum creatinine > 10 mg/dL, uremic encephalopathy (stupor, seizures), uremic pericarditis, or intractable uremic gastrointestinal bleeding.
- Acute Dialyzable Toxicities: Early removal of low-molecular-weight, water-soluble, low protein-bound toxins (e.g., Ethylene glycol within 4-6 hours of ingestion before irreversible toxic metabolite formation).
A 4-year-old male neutered domestic shorthair cat presents 24 hours after chewing on a bouquet of Easter lilies (Lilium longiflorum). Initial bloodwork reveals: Serum Creatinine 4.8 mg/dL, BUN 88 mg/dL, Phosphorus 9.2 mg/dL. Following 4 hours of IV fluid resuscitation, the cat is normotensive and fully hydrated, but urine production measured over the next 6 hours via an indwelling Foley catheter is 0.3 mL/kg/hr. According to the IRIS AKI staging system, what is the precise grade and subgrade for this patient?
A 7-year-old female German Shepherd Dog with severe oliguric AKI secondary to Leptospirosis is receiving IV fluid therapy. Which of the following clinical findings is the MOST sensitive and immediate indicator that the patient is developing dangerous intravascular fluid overload?
Which of the following pharmacologic agents is a selective Dopamine-1 (DA-1) receptor agonist that promotes renal arteriolar vasodilation and natriuresis without causing alpha-adrenergic vasoconstriction or arrhythmogenic tachycardia in critical patients?
A 3-year-old mixed-breed dog presents in anuric AKI following severe heatstroke. Despite complete fluid volume resuscitation, central venous pressure is 11 cmH2O, severe pulmonary crackles and B-lines are present on ultrasound, blood pH is 7.08, and serum potassium is 7.8 mEq/L refractory to calcium gluconate and insulin/dextrose. What is the definitive life-saving intervention indicated for this patient?